AAAAAA

   
Results: 1-25 | 26-31 |
Results: 26-31/31
CLINICAL VALIDATION OF SPECT AND CT MRI REGISTRATION IN RADIOLABELED MONOCLONAL-ANTIBODY STUDIES OF COLORECTAL-CARCINOMA/
Authors: SCOTT AM MACAPINLAC H DIVGI CR ZHANG JJ KALAIGIAN H PENTLOW K HILTON S GRAHAM MC MELIAN E SGOUROS G PELIZZARI C CHEN G GOLDSMITH SJ LARSON SM
Citation: Am. Scott et al., CLINICAL VALIDATION OF SPECT AND CT MRI REGISTRATION IN RADIOLABELED MONOCLONAL-ANTIBODY STUDIES OF COLORECTAL-CARCINOMA/, The Journal of nuclear medicine, 34(5), 1993, pp. 94-94
CLINICAL IMPLEMENTATION OF MODELING-BASED RADIOIMMUNOTHERAPY TREATMENT PLANNING - I-131 M195 ANTIBODY AGAINST CHRONIC MYELOGENOUS LEUKEMIA
Authors: SGOUROS G GRAHAM MC SCOTT A CARON PC DIVGI CR FINN R CARABASI M LARSON SM SCHEINBERG DA
Citation: G. Sgouros et al., CLINICAL IMPLEMENTATION OF MODELING-BASED RADIOIMMUNOTHERAPY TREATMENT PLANNING - I-131 M195 ANTIBODY AGAINST CHRONIC MYELOGENOUS LEUKEMIA, The Journal of nuclear medicine, 34(5), 1993, pp. 105-105
CLINICAL IMPLEMENTATION OF COMBINED 3-D AND MIRD-BASED DOSIMETRY FOR RADIOIMMUNOTHERAPY WITH I-13I CC49 MONOCLONAL-ANTIBODY (MAB)
Authors: SCOTT AM SGOUROS G DIVGI CR ZHANG JJ PENTLOW K DAGHIGIAN F WHEATLEY J MACAPINLAC H GRAHAM MC KALAIGIAN H SCHLOM J LARSON SM
Citation: Am. Scott et al., CLINICAL IMPLEMENTATION OF COMBINED 3-D AND MIRD-BASED DOSIMETRY FOR RADIOIMMUNOTHERAPY WITH I-13I CC49 MONOCLONAL-ANTIBODY (MAB), The Journal of nuclear medicine, 34(5), 1993, pp. 127-127
3-DIMENSIONAL DOSIMETRY FOR RADIOIMMUNOTHERAPY TREATMENT PLANNING
Authors: SGOUROS G CHIU S PENTLOW KS BRESTER LJ KALAIGIAN H BALDWIN B DAGHIGHIAN F GRAHAM MC LARSON SM MOHAN R
Citation: G. Sgouros et al., 3-DIMENSIONAL DOSIMETRY FOR RADIOIMMUNOTHERAPY TREATMENT PLANNING, The Journal of nuclear medicine, 34(5), 1993, pp. 162-162
EVALUATION OF CERIUM-DOPED LUTETIUM OXYORTHOSILICATE (LSO) SCINTILLATION CRYSTAL FOR PET
Authors: DAGHIGHIAN F SHENDEROV P PENTLOW KS GRAHAM MC ESHAGHIAN B MELCHER CL SCHWEITZER JS
Citation: F. Daghighian et al., EVALUATION OF CERIUM-DOPED LUTETIUM OXYORTHOSILICATE (LSO) SCINTILLATION CRYSTAL FOR PET, IEEE transactions on nuclear science, 40(4), 1993, pp. 1045-1047
A PHASE-1B TRIAL OF HUMANIZED MONOCLONAL-ANTIBODY M195 (ANTI-CD33) INMYELOID-LEUKEMIA - SPECIFIC TARGETING WITHOUT IMMUNOGENICITY
Authors: CARON PC JURCIC JG SCOTT AM FINN RD DIVGI CR GRAHAM MC JUREIDINI IM SGOUROS G TYSON D OLD LJ LARSON SM SCHEINBERG DA
Citation: Pc. Caron et al., A PHASE-1B TRIAL OF HUMANIZED MONOCLONAL-ANTIBODY M195 (ANTI-CD33) INMYELOID-LEUKEMIA - SPECIFIC TARGETING WITHOUT IMMUNOGENICITY, Blood, 82(10), 1993, pp. 10000329-10000329
Risultati: 1-25 | 26-31 |